Date: Nov 1, 2020 08:00 PM - Nov 30, 2020 05:00 PM
CE Hours
CE Units
Registration closes on Nov 30, 2020 01:00 AM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
REGISTRATION NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below: 301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
|
|
![]() |
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**
|
Co-Sponsor(s)
Support/Credits
- UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
- Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded
Registration closes on Nov 30, 2020
at 01:00 AM
Registration Closed
Meeting: 160 540 6470
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Define basic concepts of ECMO including: development, indications, and cannulation sites
- Review existing society guidelines for anticoagulation in ECMO therapy
- Discuss hematologic effects and resultant complications of ECMO therapy
- Discuss recent data supporting common anticoagulation strategies and modalities for anticoagulation monitoring
- Outline an algorithm to optimize the use of anticoagulation in ECMO therapy
Speaker(s)/Author(s)
Sydney Graboyes, PharmD
|
Activity Number
0046-9999-20-351-L01-PCE Hours
Location
Registration closes on Nov 30, 2020
at 01:00 AM
Registration Closed
Objectives
- Discuss Pharmacokinetics of oral anticoagulation in hemodialysis
- Summarize currently published literature on anticoagulation in hemodialysis
- Discuss ongoing trials analysis oral anticogaulation in dialysis
- Discuss the differences in oral anticoagulation dosing for atrial fibrillation versus venous thromboembolism treatment and prophylaxis in hemodialysis patients.
- Apply literature to a patient case
Speaker(s)/Author(s)
Rebecca Farley, PharmD
|
Activity Number
0046-9999-20-343-L01-PCE Hours
Location
Registration closes on Nov 30, 2020
at 01:00 AM
Registration Closed
Meeting:160 226 3681
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Briefly describe the pathophysiology of the SARS-CoV-2 virus and COVID-19 disease
- Review the mechanism of action, spectrum of activity, dosing regimens and the adverse effects of the novel antiviral remdesivir
- Summarize key published data on remdesivir for the treatment of COVID-19
Speaker(s)/Author(s)
Ashlyn M. Norris, PharmD
|
Activity Number
0046-9999-20-345-L01-PCE Hours
Location
Registration closes on Nov 30, 2020
at 01:00 AM
Registration Closed
Objectives
- Identify common pediatric indications for extracorporeal membrane oxygenation (ECMO) and associated complications
- Distinguish the mechanism of action of unfractionated heparin from the direct-thrombin inhibitors
- Analyze advantages and disadvantages of the anticoagulation therapeutic options in pediatric patients on ECMO
- Discuss literature pertaining to the use of alternative anticoagulation in pediatric patients on ECMO
Speaker(s)/Author(s)
Amanie Khairullah, PharmD
|